A closer look at PENELLAGEN’s starfish collagen research, its laboratory findings and the human evidence needed to assess visible skin benefits.
A report published on October 25, 2026 revisited PENELLAGEN, the starfish-derived cosmetic ingredient launched by South Korean company STAR’s Tech in 2021. It examined a peer-reviewed study from 2021 on starfish collagen peptides and elastic nanoliposomes.
Looking back at that work helps separate an unusual ingredient source from the measurements that made it scientifically interesting. The useful question is how those measurements relate to the skin benefits a reader might expect from a cosmetic.
According to the report, the study used collagen peptides from the starfish Asterias pectinifera. It examined their encapsulation in elastic nanoliposomes and a response involving MMP-1 after UV exposure. These were laboratory investigations of an ingredient and its formulation.
The nanoliposomes reportedly encapsulated a higher proportion of the starfish peptides than of the pig- or fish-derived peptides used for comparison. In plain language, this part of the research asked how much of each tested peptide material could be enclosed in the nanoliposomes.
That comparison gives the work a formulation focus. It asks a specific question about the behavior of these materials within the delivery system being studied.
The report also describes reduced UV-induced MMP-1 expression in an experiment. MMP-1 is an enzyme associated with UV-related skin aging. This finding concerns a biological response rather than the proportion of peptides encapsulated.
Keeping those outcomes separate makes the research easier to interpret. The encapsulation finding concerns the tested delivery system. The MMP-1 finding concerns an experimental response linked to UV exposure. Together they provide specific questions for further investigation.
The report does not provide the original numerical results or a detailed methods description. That leaves the size of the reported differences and the experimental conditions unavailable for close assessment here. A qualitative description of “higher” encapsulation or “reduced” expression should remain qualitative.
It also does not identify evidence from human participants. The research did not directly measure wrinkle reduction or visible skin improvement. The evidence reviewed does not establish whether PENELLAGEN reaches the dermis or demonstrate its safety and effectiveness in people.
These are distinct questions. Encapsulation concerns what is enclosed in a formulation system. Dermal delivery concerns whether material reaches the dermis. A visible cosmetic result concerns what changes in someone’s skin.
The study also involved collaboration with STAR’s Tech, and the company’s CEO was a co-author. It is therefore company-involved peer-reviewed research rather than independent confirmation of the commercial ingredient’s performance. That relationship is relevant context for judging the evidence, not a reason to discard the laboratory findings.
Peer review and independence answer different questions. Calling the paper peer-reviewed describes its publication status. Calling it company-involved describes a relationship behind the work. Both descriptions matter, but neither label should replace a careful look at what was measured.
For a product containing PENELLAGEN, the most useful next step is to ask for evidence that matches the advertised benefit. The source report specifically points toward human studies of the finished formulation with outcomes such as visible skin changes.
That turns a broad marketing question into more concrete questions:
In practical terms, keep the evidence question narrow. If the promised benefit is fewer visible wrinkles, the relevant question is whether that outcome was measured in users of the formulation. Asking that does not dismiss ingredient science. It places it in the right part of the decision.
The starfish source can be interesting without deciding a purchase. It is reasonable to wait for evidence that addresses the benefit being offered rather than treating an unfamiliar source as a reason to change an otherwise considered routine.
Younell’s guide to comparing collagen-support approaches offers a broader framework for weighing evidence against expectations. For related reading on topical care, our guide to assessing core skincare ingredients keeps the discussion focused on the kind of claim being evaluated.
Questions about a product’s suitability for an individual’s skin are best discussed with a qualified healthcare professional. An ingredient headline is not a substitute for that personal assessment.
A useful next study would connect a finished PENELLAGEN formulation with outcomes measured in people. The central question is straightforward: does the product produce a visible skin benefit under the conditions tested?
The value of that work would lie in the results and how they were measured, not simply in the unusual origin of the ingredient. For now, the reported findings offer a starting point for research. The next meaningful advance would be evidence that answers the consumer question directly.
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
